“Heroes of CRISPR” Disputed
In a perspective piece published in Cell this week (January 14), Eric Lander, president and director of the Broad Institute of MIT and Harvard, outlined the history of achievements behind the precision gene-editing technique known as CRISPR. The problem is, the Broad is a copatentee embroiled in an intellectual property battle being investigated by the US Patent and Trademark Office (USPTO). And L
Addgene: CRISPR Guide
CRISPR Overview Class 2 Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) systems, which form an adaptive immune system in bacteria, have been modified for genome engineering. Prior to CRISPR, genome engineering approaches like zinc finger nucleases (ZFNs) or transcription-activator-like effector nucleases (TALENs) required scientists to design and generate a new nuclease pair for
1
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く
Transcriptional Responses to the Environment Group
New York Genome Center (NYGC) - Homepage
The Heroes of CRISPR
Michael B. Eisen, PhD | Investigator Profile | 2008-Present
People | Columbia University Department of Systems Biology
Jennifer E. Cremins
The Center for the Development of Therapeutics (CDoT)
Eric S. Lander
Faculty | King Abdullah University
https://www.cbcb.umd.edu/~mpop/
National Centers for Biomedical Computing